tirzepatide method of action tirzepatide.pptx Tirzepatide modulates the regulation of

Liu YC, Wang H-S (2013) Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets

Semaglutide is indicated for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment such as high blood pressure, Type 2 diabetes or high cholesterol or in patients with a BMI of 30 kg/m2 or greater

It requires more research

For some researchers, the additional weight loss from higher doses is not worth the increased side effect burden, and a dose between 1.0 and 1.7 mg represents their personal optimal balance

One of their key effects is delayed gastric emptying - they literally slow down how fast food leaves your stomach, keeping you fuller for longer

10.1038/ijo.2013.120 177